Gene Testing Offers Affordable Options for Identifying Genetic Factors Linked to Cancer
Advancements in gene testing have made it more affordable and accessible for consumers to identify potential genetic factors related to cancer, according to a recent report from The Wall Street Journal. The availability of these tests allows individuals to take preventive measures and detect cancer at an early stage, yet there continues to be a lack of testing among the relatives of cancer patients.
Dr. Shoshana Ungerleider, an oncologist, shared her personal experience with gene testing following her father’s pancreatic cancer diagnosis. Through testing, it was discovered that he had a mutation of the BRCA2 gene, which significantly increases the risk of pancreatic, breast, and ovarian cancer. This revelation prompted Dr. Ungerleider to undergo her own genetic testing, and she now advocates for wider adoption of these tests among cancer patients’ relatives.
Approximately 10% of cancers are believed to have genetic links, underscoring the importance of identifying one’s increased risk for the sake of preventive measures and early detection. In the past, gene testing was a costly process that required appointments with genetic counselors. However, advancements in technology have significantly reduced the cost and made testing more accessible to the general public.
In 2018, the FDA authorized direct-to-consumer testing for specific gene mutations associated with breast and ovarian cancer, such as BRCA1 and BRCA2. Since then, additional gene variants have been included in these tests. However, it is important to remember that these tests are not diagnostic on their own and should be consulted with a healthcare professional for accurate evaluation and guidance.
The reduction in prices for gene testing has made screening tools more affordable for consumers, allowing more individuals to take advantage of this preventive measure. Beyond identifying individual risks, gene testing in cancer patients also provides valuable information for their close relatives. This information aids in the early detection and prevention of cancer.
A study published in JAMA Oncology highlights that gene testing in cancer patients can lead to more targeted and modified treatment options. By analyzing the heritable variables within the patients’ genes, doctors can develop personalized treatment plans that are more effective and minimize potential side effects.
In conclusion, the availability and affordability of gene testing have provided individuals with the opportunity to identify potential genetic factors related to cancer. While there remains a lack of testing among cancer patients’ relatives, the benefits of early detection and preventive measures cannot be ignored. With continued advancements in this field, it is crucial for individuals and healthcare professionals to embrace gene testing as a crucial tool in the fight against cancer.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”